Familial C3 glomerulonephritis caused by a novel CFHR5-CFHR2 fusion gene

Molecular Immunology

Volumn 77, Issue , 2016, Pages 89-96

  Xiao, Xue ^a   Ghossein, Cybele ^b   Tortajadam, Agustín ^c   Zhang, Yuzhou ^a   Meyer, Nicole ^a   Jones, Michael ^a   Borsa, Nicolo Ghiringhelli ^a   Nester, Carla M ^a   Thomas, Christie P ^a   de Córdoba, Santiago Rodríquez ^c   Smith, Richard J H ^a  

^a UNIVERSITY OF IOWA   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c CSIC   (Spain)

Author keywords

C3 glomerulopathy; Complement factor H related 2; Complement factor H related 5

Indexed keywords

COMPLEMENT COMPONENT C3; COMPLEMENT FACTOR H; COMPLEMENT FACTOR H RELATED 2; COMPLEMENT FACTOR H RELATED 5; PLASMA PROTEIN; UNCLASSIFIED DRUG; CFHR2 PROTEIN, HUMAN; COMPLEMENT; COMPLEMENT FACTOR I; FHR5 PROTEIN, HUMAN;

ADULT; ARTICLE; CASE REPORT; CFHR5 CFHR2 FUSION GENE; COMPARATIVE GENOMIC HYBRIDIZATION; COMPLEMENT DEPOSITION; CONTROLLED STUDY; FAMILIAL C3 GLOMERULONEPHRITIS; FAMILIAL DISEASE; FEMALE; FUSION GENE; GENE AMPLIFICATION; GENE REARRANGEMENT; GENETIC SCREENING; GLOMERULONEPHRITIS; HUMAN; HUMAN TISSUE; MULTIPLEX LIGATION DEPENDENT PROBE AMPLIFICATION; PHENOTYPE; PRIORITY JOURNAL; GENETICS; MALE; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; MULTIPLEX POLYMERASE CHAIN REACTION; PEDIGREE; WESTERN BLOTTING;

ADULT; BLOTTING, WESTERN; COMPARATIVE GENOMIC HYBRIDIZATION; COMPLEMENT C3B INACTIVATOR PROTEINS; COMPLEMENT SYSTEM PROTEINS; FEMALE; GLOMERULONEPHRITIS, MEMBRANOPROLIFERATIVE; HUMANS; MALE; MULTIPLEX POLYMERASE CHAIN REACTION; PEDIGREE;

EID: 84979894417     PISSN: 01615890     EISSN: 18729142     Source Type: Journal    
DOI: 10.1016/j.molimm.2016.07.007     Document Type: Article

References (28)

1. Abrera-Abeleda, M.A., Nishimura, C., Smith, J.L., Sethi, S., McRae, J.L., Murphy, B.F., Silvestri, G., Skerka, C., Jozsi, M., Zipfel, P.F., et al. Variations in the complement regulatory genes factor H (CFH) and factor H related 5 (CFHR5) are associated with membranoproliferative glomerulonephritis type II (dense deposit disease). J. Med. Genet. 43 (2006), 582–589.
2. Abrera-Abeleda, M.A., Nishimura, C., Frees, K., Jones, M., Maga, T., Katz, L.M., Zhang, Y., Smith, R.J., Allelic variants of complement genes associated with dense deposit disease. J. Am. Soc. Nephrol. 22 (2011), 1551–1559.
3. Athanasiou, Y., Voskarides, K., Gale, D.P., Damianou, L., Patsias, C., Zavros, M., Maxwell, P.H., Cook, H.T., Demosthenous, P., Hadjisavvas, A., et al. Familial C3 glomerulopathy associated with CFHR5 mutations: clinical characteristics of 91 patients in 16 pedigrees. Clin. J. Am. Soc. Nephrol. 6 (2011), 1436–1446.
4. Bu, F., Borsa, N.G., Jones, M.B., Takanami, E., Nishimura, C., Hauer, J.J., Azaiez, H., Black-Ziegelbein, E.A., Meyer, N.C., Kolbe, D.L., et al. High-throughput genetic testing for thrombotic microangiopathies and C3 glomerulopathies. J. Am. Soc. Nephrol., 2015.
5. Chen, Q., Wiesener, M., Eberhardt, H.U., Hartmann, A., Uzonyi, B., Kirschfink, M., Amann, K., Buettner, M., Goodship, T., Hugo, C., et al. Complement factor H-related hybrid protein deregulates complement in dense deposit disease. J. Clin. Invest. 124 (2014), 145–155.
6. Colville, D., Guymer, R., Sinclair, R.A., Savige, J., Visual impairment caused by retinal abnormalities in mesangiocapillary (membranoproliferative) glomerulonephritis type II (dense deposit disease). Am. J. Kidney Dis. 42 (2003), E2–E5.
7. Gale, D.P., de Jorge, E.G., Cook, H.T., Martinez-Barricarte, R., Hadjisavvas, A., McLean, A.G., Pusey, C.D., Pierides, A., Kyriacou, K., Athanasiou, Y., et al. Identification of a mutation in complement factor H-related protein 5 in patients of Cypriot origin with glomerulonephritis. Lancet 376 (2010), 794–801.
8. Goicoechea de Jorge, E., Caesar, J.J., Malik, T.H., Patel, M., Colledge, M., Johnson, S., Hakobyan, S., Morgan, B.P., Harris, C.L., Pickering, M.C., et al. Dimerization of complement factor H-related proteins modulates complement activation in vivo. Proc. Natl. Acad. Sci. U. S. A. 110 (2013), 4685–4690.
9. Jozsi, M., Meri, S., Factor H-related proteins. Methods Mol. Biol. 1100 (2014), 225–236.
10. Leys, A., Vanrenterghem, Y., Van Damme, B., Snyers, B., Pirson, Y., Leys, M., Fundus changes in membranoproliferative glomerulonephritis type II. A fluorescein angiographic study of 23 patients. Graefes Arch. Clin. Exp. Ophthalmol. 229 (1991), 406–410.
11. Lu, D.F., Moon, M., Lanning, L.D., McCarthy, A.M., Smith, R.J., Clinical features and outcomes of 98 children and adults with dense deposit disease. Pediatr. Nephrol. 27 (2012), 773–781.
12. Malik, T.H., Lavin, P.J., Goicoechea de Jorge, E., Vernon, K.A., Rose, K.L., Patel, M.P., de Leeuw, M., Neary, J.J., Conlon, P.J., Winn, M.P., et al. A hybrid CFHR3-1 gene causes familial C3 glomerulopathy. J. Am. Soc. Nephrol. 23 (2012), 1155–1160.
13. Medjeral-Thomas, N., Malik, T.H., Patel, M.P., Toth, T., Cook, H.T., Tomson, C., Pickering, M.C., A novel CFHR5 fusion protein causes C3 glomerulopathy in a family without Cypriot ancestry. Kidney Int. 85 (2014), 933–937.
14. Medjeral-Thomas, N.R., O'Shaughnessy, M.M., O'Regan, J.A., Traynor, C., Flanagan, M., Wong, L., Teoh, C.W., Awan, A., Waldron, M., Cairns, T., et al. C3 glomerulopathy: clinicopathologic features and predictors of outcome. Clin. J. Am. Soc. Nephrol. 9 (2014), 46–53.
15. Montes, T., Goicoechea de Jorge, E., Ramos, R., Goma, M., Pujol, O., Sanchez-Corral, P., Rodriguez de Cordoba, S., Genetic deficiency of complement factor H in a patient with age-related macular degeneration and membranoproliferative glomerulonephritis. Mol. Immunol. 45 (2008), 2897–2904.
16. Neary, J., Dorman, A., Campbell, E., Keogan, M., Conlon, P., Familial membranoproliferative glomerulonephritis type III. Am. J. Kidney Dis., 40, 2002, E1.
17. Neary, J.J., Conlon, P.J., Croke, D., Dorman, A., Keogan, M., Zhang, F.Y., Vance, J.M., Pericak-Vance, M.A., Scott, W.K., Winn, M.P., Linkage of a gene causing familial membranoproliferative glomerulonephritis type III to chromosome 1. J. Am. Soc. Nephrol. 13 (2002), 2052–2057.
18. Pickering, M.C., D'Agati, V.D., Nester, C.M., Smith, R.J., Haas, M., Appel, G.B., Alpers, C.E., Bajema, I.M., Bedrosian, C., Braun, M., et al. C3 glomerulopathy: consensus report. Kidney Int. 84 (2013), 1079–1089.
19. Servais, A., Fremeaux-Bacchi, V., Lequintrec, M., Salomon, R., Blouin, J., Knebelmann, B., Grunfeld, J.P., Lesavre, P., Noel, L.H., Fakhouri, F., Primary glomerulonephritis with isolated C3 deposits: a new entity which shares common genetic risk factors with haemolytic uraemic syndrome. J. Med. Genet. 44 (2007), 193–199.
20. Servais, A., Noel, L.H., Roumenina, L.T., Le Quintrec, M., Ngo, S., Dragon-Durey, M.A., Macher, M.A., Zuber, J., Karras, A., Provot, F., et al. Acquired and genetic complement abnormalities play a critical role in dense deposit disease and other C3 glomerulopathies. Kidney Int. 82 (2012), 454–464.
21. Servais, A., Noel, L.H., Fremeaux-Bacchi, V., Lesavre, P., C3 glomerulopathy. Contrib. Nephrol. 181 (2013), 185–193.
22. Sethi, S., Gamez, J.D., Vrana, J.A., Theis, J.D., Bergen, H.R. 3rd, Zipfel, P.F., Dogan, A., Smith, R.J., Glomeruli of dense deposit disease contain components of the alternative and terminal complement pathway. Kidney Int. 75 (2009), 952–960.
23. Sethi, S., Sukov, W.R., Zhang, Y., Fervenza, F.C., Lager, D.J., Miller, D.V., Cornell, L.D., Krishnan, S.G., Smith, R.J., Dense deposit disease associated with monoclonal gammopathy of undetermined significance. Am. J. Kidney Dis. 56 (2010), 977–982.
24. Sethi, S., Fervenza, F.C., Zhang, Y., Zand, L., Vrana, J.A., Nasr, S.H., Theis, J.D., Dogan, A., Smith, R.J., C3 glomerulonephritis: clinicopathological findings, complement abnormalities, glomerular proteomic profile, treatment, and follow-up. Kidney Int. 82 (2012), 465–473.
25. Skerka, C., Chen, Q., Fremeaux-Bacchi, V., Roumenina, L.T., Complement factor H related proteins (CFHRs). Mol. Immunol. 56 (2013), 170–180.
26. Tortajada, A., Yebenes, H., Abarrategui-Garrido, C., Anter, J., Garcia-Fernandez, J.M., Martinez-Barricarte, R., Alba-Dominguez, M., Malik, T.H., Bedoya, R., Cabrera Perez, R., et al. C3 glomerulopathy-associated CFHR1 mutation alters FHR oligomerization and complement regulation. J. Clin. Invest. 123 (2013), 2434–2446.
27. Zhang, Y., Meyer, N.C., Wang, K., Nishimura, C., Frees, K., Jones, M., Katz, L.M., Sethi, S., Smith, R.J., Causes of alternative pathway dysregulation in dense deposit disease. Clin. J. Am. Soc. Nephrol. 7 (2012), 265–274.
28. Zhang, Y., Nester, C.M., Martin, B., Skjoedt, M.O., Meyer, N.C., Shao, D., Borsa, N., Palarasah, Y., Smith, R.J., Defining the complement biomarker profile of C3 glomerulopathy. Clin. J. Am. Soc. Nephrol. 9 (2014), 1876–1882.